NCT00814710View on ClinicalTrials.gov

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 7, 2009

Primary Completion Date

November 13, 2009

Study Completion Date

November 13, 2009

Conditions
Infections, StreptococcalStreptococcus Pneumoniae
Interventions
BIOLOGICAL

Pneumococcal conjugate vaccine GSK1024850A

Intramuscular injection, 3 doses

BIOLOGICAL

Tritanrix-HepB/Hib

Intramuscular injection, 3 doses

BIOLOGICAL

Hiberix

Intramuscular injection, 3 doses

BIOLOGICAL

Tritanrix-HepB

Intramuscular injection, 3 doses

Trial Locations (4)

632004

GSK Investigational Site, Vellore

700073

GSK Investigational Site, Kolkata

141 008

GSK Investigational Site, Ludhiana

Unknown

GSK Investigational Site, Pune

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00814710 - Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age | Biotech Hunter | Biotech Hunter